Showing Results : 1-1 of 1
Sort By :
Journal of the Egyptian National Cancer Institute

Published By SpringerOpen

  • Journal of the Egyptian National Cancer Institute: 2023, vol: 35, issue: 1
  • 1)- Avinash Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala. Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 1
    Cited : 1
    Read More
  • 2)- F Safini, B Amaoui, S Semghouli, N Aqodad. Organ preservation strategy: new therapeutic alternative in rectal cancer. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 10
    Cited : 0
    Read More
  • 3)- Ahmed Daif, Mahmood A Al-Azzawi, Moustafa A Sakr, Hisham A Ismail, Mahmoud Gadallah. Noninvasive identification of molecular biomarkers of hepatocellular carcinoma in HCV-Egyptian patients. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 11
    Cited : 1
    Read More
  • 4)- Eman Mohamad Ibrahim, Sherine Refat, Shaimaa El-Ashwah, Maryan Waheeb Fahmi, Afaf Taha Ibrahiem. Programmed death ligand 1 expression in diffuse large B cell lymphoma: correlation with clinicopathological prognostic factors. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 12
    Cited : 2
    Read More
  • 5)- Ibrahim Abdelrahman, Hatem Aboulkassem, Abdallah Elazab, Ahmed Younis Abdallah, Yahia Ismail, Mohammad Taher. Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 13
    Cited : 0
    Read More
  • 6)- Patrick Odhiambo, Harrison Okello, Annette Wakaanya, Clabe Wekesa, Patrick Okoth. Mutational signatures for breast cancer diagnosis using artificial intelligence. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 14
    Cited : 0
    Read More
  • 7)- Iyshwarya Bhaskar Kalarani, Ganesan Sivamani, Ramakrishnan Veerabathiran. Identification of crucial genes involved in thyroid cancer development. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 15
    Cited : 3
    Read More
  • 8)- Yahia Ismail, Amr Kamal, Rasha Allam, Al-Shimaa Zakaria. The conundrum of metaplastic breast cancer: a single Egyptian institution retrospective 10-year experience (2011-2020). Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 16
    Cited : 2
    Read More
  • 9)- Mona S El Ashry, Enas Radwan, Mona S Abdellateif, Omar Arafah, Naglaa M Hassan. Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 17
    Cited : 0
    Read More
  • 10)- Mahdiyar Iravani Saadi, Mohsen Nikandish, Zahra Ghahramani, Fatemeh Mardani Valandani, Maryam Ahmadyan, Fakhroddin Hosseini, Zahra Rahimian, Heeva Jalali, Fataneh Tavasolian, Ehsan Nabi Abdolyousefi, Nadiya Kheradmand, Mani Ramzi. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 18
    Cited : 0
    Read More
  • 11)- Rashed Pourhamidi, Azam Moslemi. Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 19
    Cited : 0
    Read More
  • 12)- Alaa Younes, Mohammad Fouad Taher, Iman Sidhom, Wael Zekri, Iman Zaky, Habiba Elfendy, Azza Niazy Taher, Suzan Adlan Khedr, Rana Gamal, Gehad Ahmed. Parotid gland masses: outcomes in the pediatric age group. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 2
    Cited : 0
    Read More
  • 13)- Alex Mwesigwa Mugisha, Zeridah Muyinda, Joyce Balagadde Kambugu, Denise Apolot, Elizabeth Atugonza, Anneth Teu, Aloysius Gonzaga Mubuuke. Observer agreement in single computerized tomography use for diagnosing paediatric head and neck malignancies at Uganda Cancer Institute. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 20
    Cited : 0
    Read More
  • 14)- Mohammed Shahait, Ramiz Abu-Hijlih, Ala'a Farkouh, Shahed Obeidat, Samer Salah, Ahmed Saad Abdlkadir, Akram Al-Ibraheem. Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 21
    Cited : 1
    Read More
  • 15)- Seema Sandeep Redekar, Satishkumar L Varma, Atanu Bhattacharjee. Gene co-expression network construction and analysis for identification of genetic biomarkers associated with glioblastoma multiforme using topological findings. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 22
    Cited : 2
    Read More
  • 16)- Emmanuel D Morgan, James J Yahaya, Advera I Ngaiza, Emmanuel Othieno, Okwi A Livex. Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 23
    Cited : 1
    Read More
  • 17)- Sagiru Hamza Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba, Abdullahi Bello Umar. Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 24
    Cited : 2
    Read More
  • 18)- Nour Pharaon, Wafa Habbal, Fawza Monem. Bioinformatic analysis of KIT juxtamembrane domain mutations in Syrian GIST patients: jigsaw puzzle completed. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 25
    Cited : 1
    Read More
  • 19)- Mahmoud El-Bendary, Khaled Farid, Mohammad Arafa, Wagdi Elkashef, Talaat Abdullah, Ahmed El-Mesery. Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 26
    Cited : 0
    Read More
  • 20)- Shinjini Bandopadhyay, Somi Patranabis. Mechanisms of HIF-driven immunosuppression in tumour microenvironment. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 27
    Cited : 0
    Read More
  • 21)- Azza El-Amir, Eman M El-Baiomy, Noha A Sabry, Loay Kassem, Margaret A Chesney, Kenneth A Wallston. The relationship between coping self-efficacy and B cells in breast cancer patients. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 28
    Cited : 0
    Read More
  • 22)- Nesreen Ali, Mohamed Mansour, Ehab Khalil, Emad Ebeid. Outcome and prognostic factors of pediatric patients with Hodgkin lymphoma: a single-center experience. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 29
    Cited : 0
    Read More
  • 23)- Umesh Jayarajah, Ravindri Jayasinghe, Ashan Fernando, Sanjeewa Seneviratne. The incidence and trends of laryngeal malignancies in Sri Lanka from 2001 to 2019: a Joinpoint analysis of the national cancer database. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 3
    Cited : 0
    Read More
  • 24)- Hatem Wael Amer, Hana'a Hezam Algadi, Shyma'a Ahmed Hamza. Mandibular small cell osteosarcoma: a case report and review of literature. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 30
    Cited : 0
    Read More
  • 25)- Alaa Elnaggar, Gihane Madkour, Neveen Tahoun, Ayman Amin, Fat'heya M Zahran. Micronuclei detection in oral cytologic smear: does it add diagnostic value? Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 31
    Cited : 0
    Read More
  • 26)- Mengxiao Lu, Yingjie Wu, Yixin Zhang, Yu Yu, ShengJie Wang, Xiaobao Su. Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 32
    Cited : 1
    Read More
  • 27)- Ghada M Al-Toukhy, Reda A Suef, Sarah Hassan, Mohamed M S Farag, Tarek A El-Tayeb, Mohamed T M Mansour. Photobiological modulation of hepatoma cell lines and hepatitis B subviral particles secretion in response to 650 nm low level laser treatment. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 33
    Cited : 0
    Read More
  • 28)- Nihal Mohamed Ahmed Darwish, Hatem Wael Abdel-Fattah Amer, Nesma Nabil Mohamed Mahrous. Ameloblastic fibro-dentinoma: a rare mixed odontogenic tumor case report with review of literature. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 34
    Cited : 1
    Read More
  • 29)- Mona S Abdellateif, Abdel-Rahman N Zekri. Stem cell therapy for hepatocellular carcinoma and end-stage liver disease. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 35
    Cited : 0
    Read More
  • 30)- Sarah S Nasr, Ghada M Sherif, Maha Abdel Wahab, Hatem Aboelkasem. Targeting average length of hospital stay as a control measure to decrease COVID-19 hospital-acquired infection in surgical cancer patients. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 36
    Cited : 0
    Read More
  • 31)- Mehwish Shahzadi, Saqib Raza Khan, Muhammad Tariq, Sehrish Sarwar Baloch, Aisha Shahid, Munira Moosajee, Zarka Samon. Review of current literature on gestational trophoblastic neoplasia. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 37
    Cited : 0
    Read More
  • 32)- Maxwell Akonde, Eric Mishio Bawa, Ottovon Bismark Dakurah, Rajat Das Gupta. Impact of family history of cancer on colorectal cancer screening: a propensity score-matched analysis from the Health Information National Trends Survey (HINTS). Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 38
    Cited : 0
    Read More
  • 33)- Rogomenoma Alice Ouedraogo, Ali Kande, Wendyam Marie Christelle Nadembega, Djeneba Ouermi, Théodora Mahoukèdè Zohoncon, Florencia Wendkuuni Djigma, Charlemagne Marie Ragnag-Newende Ouedraogo, Olga Mélanie Lompo, Jacques Simpore. Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 39
    Cited : 1
    Read More
  • 34)- Sanaa A El-Benhawy, Ibrahim G Abdelrhman, Nadia A Sadek, Enayat I Fahmy, Ahmed A AboGabal, Hossam Elmasry, Sally A M Saleh, Ola A Sakr, Mona Nagy Elwany, Maha Abubakr Feissal Rabie. Studying ferroptosis and iron metabolism pre- and post-radiotherapy treatment in breast cancer patients. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 4
    Cited : 2
    Read More
  • 35)- Munehiro Wakabayashi, Yoshinori Kikuchi, Kazuhisa Yamaguchi, Takahisa Matsuda. Prognosis of pancreatic cancer with Trousseau syndrome: a systematic review of case reports in Japanese literature. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 40
    Cited : 0
    Read More
  • 36)- Qiang Wang, Wei Fan, ZengHui Hao, Bingxue Liang, Meili Fan, Zijian Zhao, Zhaozhu Li. REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via STAT3/VEGF signaling. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 41
    Cited : 0
    Read More
  • 37)- Amira M Mohammed, Hosney B Hamed, Maisa K Noaman, Nelly Alieldin. Metabolic syndrome and breast cancer risk. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 42
    Cited : 1
    Read More
  • 38)- Radhika Arora, Feroz Alam, Atia Zaka-Ur-Rab, Veena Maheshwari, Kiran Alam, Mahboob Hasan. Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 43
    Cited : 2
    Read More
  • 39)- Hesham Abdel-Azim El-Helaly, Asem Abdel-Aziz Mahmoud, Ahmed Mohamed Magdy, Abdelwahab Hasehem, Hamdy Mohamed Ibrahim, Khaled Moheyelden Mohamed, Mohamed Hamdy Ismail. Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 5
    Cited : 0
    Read More
  • 40)- Nur Dina Amalina, Irfani Aura Salsabila, Ummi Maryam Zulfin, Riris Istighfari Jenie, Edy Meiyanto. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 6
    Cited : 5
    Read More
  • 41)- Mohamed Said Ismail, Loay Kassem, Ahmed Al-Husseiny Ali, Fatma Elzahraa Ahmed, Mohamed Shalaby, Sally Magdy. Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 7
    Cited : 0
    Read More
  • 42)- Mousa Fadaei, Maryam Kohansal, Omidreza Akbarpour, Mahsa Sami, Ali Ghanbariasad. Network and functional analyses of differentially expressed genes in gastric cancer provide new biomarkers associated with disease pathogenesis. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 8
    Cited : 0
    Read More
  • 43)- Mai Sabry Saleh, Asmaa Mahmoud Mohammed, Dina Bassiouni, Hend Helmy Mostafa, Zeinab Mohammed Monir. Evaluation of health-related quality of life and its domains in pediatric patients with cancer. Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 9
    Cited : 0
    Read More
 
 


Journal List
Links
Content Links
About Us

0